Efficacy and Safety Of Infliximab Or Adalimumab Vs Abatacept In Patients With Rheumatoid Arthritis and An Inadequate Response To Methotrexate: Attest-Ample Network Randomized Trial

被引：0
|
作者：
Christensen, Robin [1 ,2 ]
Tarp, Simon [1 ,2 ]
Furst, Daniel E. [3 ]
Kristensen, Lars E. [4 ]
Bliddal, Henning [1 ,2 ]
机构：
[1] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Musculoskeletal Stat Unit, Bispebjerg, Denmark
[2] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Musculoskeletal Stat Unit, Frederiksberg, Denmark
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Lund Univ, Rheumatol Sect, Dept Clin Sci, Lund, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
499
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [41] The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
    Weinblatt, Michael E.
    Mease, Philip
    Mysler, Eduardo
    Takeuchi, Tsutomu
    Drescher, Edit
    Berman, Alberto
    Xing, Jun
    Zilberstein, Moshe
    Banerjee, Subhashis
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (10) : 2591 - 2600
  • [42] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: 52-Week Results
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon-Campos, J-Abraham
    Baraf, Herbert S.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Mozaffarian, Neelufar
    Landewe, Robert
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [43] Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate
    Shin, Kichul
    Baek, Han Joo
    Kang, Young Mo
    Cha, Hoon-Suk
    Kang, Seong Wook
    Park, Sung-Hwan
    Jun, Jae-Bum
    Lee, Yun Jong
    Choi, In Ah
    Song, Yeong Wook
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (06) : 1115 - 1122
  • [44] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 47
  • [45] Sustainability of Response Between Upadacitinib and Adalimumab Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [46] Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial
    Kremer, Joel M.
    Genant, Harry K.
    Moreland, Larry W.
    Russell, Anthony S.
    Emery, Paul
    Abud-Mendoza, Carlos
    Szechinski, Jacek
    Li, Tracy
    Ge, Zhiyu
    Becker, Jean-Claude
    Westhovens, Rene
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) : 865 - 876
  • [47] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon, J. Abraham
    Baraf, Herbert S. B.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Genovese, Mark C.
    Mozaffarian, Neelufar
    Landewe, Robert B. M.
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 848 - 858
  • [48] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, P.
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 643 - 644
  • [49] 2-Year Results From The Ample (Abatacept versus Adalimumab Comparison in Biologic-Naive RA Patients with Background Methotrexate) Trial: Changes In Patient-Reported Outcomes In Response To Subcutaneous Abatacept Or Adalimumab In Rheumatoid Arthritis
    Fleischmann, R.
    Weinblatt, M. E.
    Schiff, M.
    Khanna, D.
    Maldonado, M. A.
    Nadkarni, A.
    Furst, D. E.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S183 - S183
  • [50] 2-Year Results from the AMPLE (Abatacept versus Adalimumab Comparison in Biologic-Naive RA Patients with Background Methotrexate) Trial: Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis
    Fleischmann, Roy
    Weinblatt, Michael
    Schiff, Michael
    Khanna, Dinesh
    Maldonado, Michael
    Nadkarni, Anagha
    Furst, Daniel
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1475 - 1476
12345